Tyra Biosciences, Inc (TYRA) insider trading
Every open-market stock purchase and sale by Tyra Biosciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $10.6M over the last 12 months (8 sales). No open-market buys.
- Last insider buy: Ra Capital Management L.p. (Insider), $120K, 16 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $10.6M (8 sales). Last close $26.75 on Jun 7, 2026.
Recent TYRA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 28, 2026 | Ra Capital Management L.p. (Insider) | Bought (not open market) | — |
| May 28, 2026 | Adele M. Gulfo (Insider) | Bought (not open market) | — |
| May 28, 2026 | Robert J More (Insider) | Bought (not open market) | — |
| May 28, 2026 | Susan Moran (Insider) | Bought (not open market) | — |
| May 28, 2026 | Stephen Michael Rothenberg (Insider) | Bought (not open market) | — |
| May 28, 2026 | Jake Simson (Insider) | Bought (not open market) | — |
| May 28, 2026 | Rehan Verjee (Insider) | Bought (not open market) | — |
| May 5, 2026 | Yuliya Rueb (President) | Bought (not open market) | — |
| May 5, 2026 | Todd Harris (CEO) | Bought (not open market) | — |
| May 5, 2026 | Todd Harris (CEO) | Bought (not open market) | — |
| May 5, 2026 | Yuliya Rueb (President) | Bought (not open market) | — |
| May 5, 2026 | Douglas J Warner (C-suite exec) | Bought (not open market) | — |
| May 5, 2026 | Douglas J Warner (C-suite exec) | Bought (not open market) | — |
| May 5, 2026 | Alan Fuhrman (CFO) | Bought (not open market) | — |
| May 5, 2026 | Alan Fuhrman (CFO) | Bought (not open market) | — |
| May 5, 2026 | Bhavesh Ashar (COO) | Bought (not open market) | — |
| May 5, 2026 | Bhavesh Ashar (COO) | Bought (not open market) | — |
| Apr 16, 2026 | Habib J Dable (Insider) | Bought (not open market) | — |
| Mar 26, 2026 | Gilla Kaplan (Insider) | Sold (not open market) | $2M |
| Mar 26, 2026 | Gilla Kaplan (Insider) | Bought (not open market) | — |
| Mar 25, 2026 | Gilla Kaplan (Insider) | Sold | $529K |
| Mar 25, 2026 | Gilla Kaplan (Insider) | Bought (not open market) | — |
| Mar 13, 2026 | Todd Harris (CEO) | Bought (not open market) | $13.4K |
| Mar 13, 2026 | Alan Fuhrman (CFO) | Bought (not open market) | $12.6K |
| Feb 12, 2026 | Daniel Bensen (C-suite exec) | Sold | $196K |
Who's trading TYRA
- Jake Simson, Insider: other filings, last May 28, 2026
- Susan Moran, Insider: other filings, last May 28, 2026
- Robert J More, Insider: sold $5.3M (2 sales), last May 28, 2026
- Stephen Michael Rothenberg, Insider: other filings, last May 28, 2026
- Ra Capital Management L.p., Insider: other filings, last May 28, 2026
- Rehan Verjee, Insider: other filings, last May 28, 2026
- Adele M. Gulfo, Insider: other filings, last May 28, 2026
- Douglas J Warner, C-suite exec: other filings, last May 5, 2026
- Alan Fuhrman, CFO: other filings, last May 5, 2026
- Todd Harris, CEO: other filings, last May 5, 2026
- Yuliya Rueb, President: other filings, last May 5, 2026
- Bhavesh Ashar, COO: other filings, last May 5, 2026
- Habib J Dable, Insider: other filings, last Apr 16, 2026
- Gilla Kaplan, Insider: sold $529K (1 sale), last Mar 26, 2026
- Daniel Bensen, COO: sold $4.8M (11 sales), last Feb 12, 2026
Get free alerts when an insider at Tyra Biosciences, Inc files a new trade →